CNSI, backed by Carlyle and a provider of healthcare technology products and services, has merged with Kepro, a care management quality oversight and clinical assessment service company backed by Apax Partners LLP.

The combined company aims to help government-sponsored healthcare agencies and payers expand healthcare access, improve quality and health outcomes and lower costs through its clinical services, provider management, health claims and encounter processing, interoperability and health analytics services. The newly merged company looks to rebrand in early 2023. Apax will be exiting its investment in Kepro through this transaction, and Carlyle will back the new company.

“The combination of CNSI and Kepro aligns with the strategic objectives of both companies to deploy technology-enabled products, solutions, and services that help our clients achieve their mission and better serve their priority populations,” comments Todd Stottlemyer. “I am excited about our ability to provide a full array of services and solutions that will help our clients meet the holistic health needs of those they serve.”

Latham & Watkins LLP acted as legal advisor to CNSI and Carlyle. Centerview Partners acted as an investment advisor to Kepro and Apax, and Kirkland & Ellis served as legal advisor to both Kepro and Apax.